by Jordana Choucair | Jul 1, 2022 | Life Sciences
Senate Democrats plan to submit a revised proposal to lower prescription drug prices for a key procedural review in the coming days as they press forward with preparations for a vote on Biden’s economic package. The plan would allow Medicare to negotiate lower prices...
by Jordana Choucair | Jun 30, 2022 | Life Sciences
The Biden administration announced that it will purchase 105 million doses of an updated Pfizer COVID-19 vaccine, pending Food and Drug Administration (FDA) approval. The updated vaccine is expected to target the omicron variant, with the goal of providing improved...
by Jordana Choucair | Jun 30, 2022 | Life Sciences
Pfizer and BioNTech announced they will initiate clinical trials of pan-coronavirus vaccines in the second half of the year. The company said it wants to provide “durable variant protection.” Universal vaccines have been studied with limited success for...
by Jordana Choucair | Jun 29, 2022 | Life Sciences
An expert advisory vaccine panel for the Food and Drug Administration (FDA) recommended updated COVID-19 vaccines specifically designed to combat the omicron variant. Nineteen members of the Vaccines and Related Biological Products Advisory Committee voted in favor of...
by Jordana Choucair | Jun 29, 2022 | Life Sciences
A group of 100 federal lawmakers is urging the Biden administration to use controversial provisions of federal law to lower prescription drug prices. The lawmakers sent a letter to HHS Secretary Xavier Becerra to discuss the issue, reiterating calls for the...
by Jordana Choucair | Jun 27, 2022 | Life Sciences
Pfizer and BioNTech announced Saturday that updated versions of their COVID-19 vaccines deliver a “substantially higher immune response” against the omicron strain. Monovalent targets omicron alone while bivalent combines monovalent with the companies’ original...
Recent Comments